microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway

Feng-Juan Han1, Jia Li2, Ying Shen2

  • 1Department of Gynecology, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, 150040, Heilongjiang, China.

Journal of Ovarian Research
|September 19, 2020
PubMed
Abstract

Insights

MicroRNA-1271-5p inhibits ovarian cancer progression by targeting TIAM1 and inactivating the Notch pathway. This finding offers a potential new therapeutic strategy for ovarian cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer (OC) is a highly malignant gynecological neoplasm with frequent metastasis and recurrence.
  • MicroRNA-1271-5p (miR-1271-5p) has been linked to OC progression, but its mechanism remains unclear.

Purpose of the Study:

  • To investigate the role and mechanism of miR-1271-5p in regulating ovarian cancer progression.

Main Methods:

  • Analysis of Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases.
  • qRT-PCR, CCK-8, colony formation, and Transwell assays to assess cell behavior.
  • Bioinformatics, luciferase assays, and Western blot to identify and validate miR-1271-5p targets and pathways.

Main Results:

  • miR-1271-5p was downregulated in OC and associated with poor prognosis.
  • miR-1271-5p suppressed OC cell viability, proliferation, migration, and invasion.
  • TIAM1 was identified as a direct target of miR-1271-5p, with high TIAM1 expression correlating with poor OC prognosis.
  • Upregulation of TIAM1 counteracted the inhibitory effects of miR-1271-5p on OC cell malignancy, impacting Notch signaling pathway proteins (Cyclin D1, HES1, NOTCH, NUMB).

Conclusions:

  • miR-1271-5p inhibits OC cell proliferation, invasion, and migration by directly repressing TIAM1.
  • This repression inactivates the Notch signaling pathway, suggesting miR-1271-5p as a potential therapeutic target for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K